These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 26193243)
1. Three-dimensional compound comparison methods and their application in drug discovery. Shin WH; Zhu X; Bures MG; Kihara D Molecules; 2015 Jul; 20(7):12841-62. PubMed ID: 26193243 [TBL] [Abstract][Full Text] [Related]
2. Virtual Ligand Screening Using PL-PatchSurfer2, a Molecular Surface-Based Protein-Ligand Docking Method. Shin WH; Kihara D Methods Mol Biol; 2018; 1762():105-121. PubMed ID: 29594770 [TBL] [Abstract][Full Text] [Related]
3. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition. Wei NN; Hamza A J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054 [TBL] [Abstract][Full Text] [Related]
4. PatchSurfers: Two methods for local molecular property-based binding ligand prediction. Shin WH; Bures MG; Kihara D Methods; 2016 Jan; 93():41-50. PubMed ID: 26427548 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive comparative assessment of 3D molecular similarity tools in ligand-based virtual screening. Jiang Z; Xu J; Yan A; Wang L Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34151363 [TBL] [Abstract][Full Text] [Related]
6. AutoDock-SS: AutoDock for Multiconformational Ligand-Based Virtual Screening. Ni B; Wang H; Khalaf HKS; Blay V; Houston DR J Chem Inf Model; 2024 May; 64(9):3779-3789. PubMed ID: 38624083 [TBL] [Abstract][Full Text] [Related]
7. PL-PatchSurfer2: Improved Local Surface Matching-Based Virtual Screening Method That Is Tolerant to Target and Ligand Structure Variation. Shin WH; Christoffer CW; Wang J; Kihara D J Chem Inf Model; 2016 Sep; 56(9):1676-91. PubMed ID: 27500657 [TBL] [Abstract][Full Text] [Related]
8. Application of support vector machine to three-dimensional shape-based virtual screening using comprehensive three-dimensional molecular shape overlay with known inhibitors. Sato T; Yuki H; Takaya D; Sasaki S; Tanaka A; Honma T J Chem Inf Model; 2012 Apr; 52(4):1015-26. PubMed ID: 22424085 [TBL] [Abstract][Full Text] [Related]
9. Structure-Based Virtual Screening. Li Q; Shah S Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235 [TBL] [Abstract][Full Text] [Related]
10. Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology. Ballester PJ; Finn PW; Richards WG J Mol Graph Model; 2009 Apr; 27(7):836-45. PubMed ID: 19188082 [TBL] [Abstract][Full Text] [Related]
11. PL-PatchSurfer3: Improved Structure-Based Virtual Screening for Structure Variation Using 3D Zernike Descriptors. Shin WH; Kihara D bioRxiv; 2024 Feb; ():. PubMed ID: 38464318 [TBL] [Abstract][Full Text] [Related]
12. Three-Dimensional Biologically Relevant Spectrum (BRS-3D): Shape Similarity Profile Based on PDB Ligands as Molecular Descriptors. Hu B; Kuang ZK; Feng SY; Wang D; He SB; Kong DX Molecules; 2016 Nov; 21(11):. PubMed ID: 27869685 [TBL] [Abstract][Full Text] [Related]
13. Performance evaluation of 2D fingerprint and 3D shape similarity methods in virtual screening. Hu G; Kuang G; Xiao W; Li W; Liu G; Tang Y J Chem Inf Model; 2012 May; 52(5):1103-13. PubMed ID: 22551340 [TBL] [Abstract][Full Text] [Related]
14. LS-align: an atom-level, flexible ligand structural alignment algorithm for high-throughput virtual screening. Hu J; Liu Z; Yu DJ; Zhang Y Bioinformatics; 2018 Jul; 34(13):2209-2218. PubMed ID: 29462237 [TBL] [Abstract][Full Text] [Related]
15. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics. Kumar R; Jade D; Gupta D J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945 [TBL] [Abstract][Full Text] [Related]
16. Unconventional 2D shape similarity method affords comparable enrichment as a 3D shape method in virtual screening experiments. Ebalunode JO; Zheng W J Chem Inf Model; 2009 Jun; 49(6):1313-20. PubMed ID: 19480404 [TBL] [Abstract][Full Text] [Related]
17. Quantum probability ranking principle for ligand-based virtual screening. Al-Dabbagh MM; Salim N; Himmat M; Ahmed A; Saeed F J Comput Aided Mol Des; 2017 Apr; 31(4):365-378. PubMed ID: 28220440 [TBL] [Abstract][Full Text] [Related]
18. Rationalizing the role of SAR tolerance for ligand-based virtual screening. Ripphausen P; Nisius B; Wawer M; Bajorath J J Chem Inf Model; 2011 Apr; 51(4):837-42. PubMed ID: 21438544 [TBL] [Abstract][Full Text] [Related]
19. Ligand-based virtual screening under partial shape constraints. von Behren MM; Rarey M J Comput Aided Mol Des; 2017 Apr; 31(4):335-347. PubMed ID: 28315995 [TBL] [Abstract][Full Text] [Related]
20. An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs. Xia J; Jin H; Liu Z; Zhang L; Wang XS J Chem Inf Model; 2014 May; 54(5):1433-50. PubMed ID: 24749745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]